Valley National Advisers’s Verrica Pharmaceuticals VRCA Stock Holding History

Valley National Advisers’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$153	Buy	+25	New	+$156	﹤0.01%	1019

Other funds holding VRCA

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

NECFA

New England Capital Financial Advisors Meriden, Connecticut $418M AUM 16.7% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Valley National Advisers's VRCA Position: Q2 2026 in Review

Valley National Advisers opened a new position in Verrica Pharmaceuticals (VRCA) in Q2 2026: 25 shares worth $153. The stake represents ﹤0.01% of the portfolio and ranks #1019 among its holdings.

5 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

Valley National Advisers held 25 shares of Verrica Pharmaceuticals worth $153 as of Q2 2026.
Verrica Pharmaceuticals was a new Valley National Advisers position in Q2 2026.
Verrica Pharmaceuticals made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #1019 holding.
5 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.